ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Excerpts Presented From Pepper Hearing

July 20, 1979

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005